Clinical trialObservationalActive not recruiting
Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes
- Outcome
- Ongoing
- Phase
- Observational
- Status
- Active not recruiting
- Study type
- Observational
- Start
- 12 July 2016
- Expected end
- September 2027
- Enrollment
- 1,047 participants
- Sites
- 5
- Primary outcomes
- baseline to post-results change in distress levels
- Sponsor type
- Academic / other
- Results posted
- No
- Last update
- 5 October 2026
These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
This study will evaluate patients' experiences with having gynecologic or prostate medical oncologists and surgeons offer them genetic testing, and having genetic counselors return the test results to patients over the telephone. This is different from the usual approach to genetic testing, where gynecologic or prostate medical oncologists and surgeons refer their patients to a genetic counselor in order to have these tests done, and the genetic counselors return the test results to the patient in person or over the telephone. The investigators will only be evaluating this alternative way of providing genetic testing to ovarian or prostate cancer patients.